skip to main content

CKD G3b — ESENeph MCQ

Instant feedback + full explanation. One question, done properly.

HardPerioperative Cardiovascular Management for Noncardiac SurgeryCKD G3bESENeph

An adult with CKD anaemia is receiving an erythropoiesis-stimulating agent. Which haemoglobin range should treatment usually maintain?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: D100–120 g/L

The best answer is “100–120 g/L”. NICE recommends maintaining haemoglobin between 100 and 120 g/L in adults receiving erythropoiesis-stimulating treatment, with dose adjustment when values move outside the action thresholds. Lower ranges leave clinically important anaemia undertreated, while deliberate normalisation above this range exposes patients to avoidable vascular risk.

Reference: NICE NG8 chronic kidney disease anaemia recommendations: https://www.nice.org.uk/guidance/ng8/chapter/recommendations